Jazz Pharmaceuticals plc Available-for-sale Securities, Amortized Cost Basis
Jazz Pharmaceuticals plc (JAZZ) had Available-for-sale Securities, Amortized Cost Basis of $708.17 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-05-08
- 2018-03-31: Available-for-sale Securities, Amortized Cost Basis $708.17M.
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $601.03M.
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $452.62M.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $319.21M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2018-03-31 | $708.17M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $601.03M 10-Q · filed 2018-05-08 | |
| 2017-09-30 | $452.62M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $319.21M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $407.00M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $425.96M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $425.99M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $916.38M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $980.54M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $988.78M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $998.86M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $921.64M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $782.60M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $684.04M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $575.04M 10-Q · filed 2014-11-04 | |
| 2014-03-31 | $251.38M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $636.50M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $588.46M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $504.31M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $450.51M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $387.20M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $189.79M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $154.54M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $139.57M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $157.93M 10-K · filed 2013-02-26 | $124.62M 10-K · filed 2012-02-28 |
| 2010-12-31 | $25.05M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |